Starpharma Holdings LimitedASX: SPL

Application for quotation of securities - SPL

· Issued by Starpharma Holdings Limited

Summary by 6ix AI

Starpharma Holdings Limited applied on October 30, 2026 to the Australian Securities Exchange (ASX) for quotation of 3,171,938 new ordinary fully paid shares. The shares were issued on October 23, 2026 when vested employee performance rights were converted into ordinary shares at no cost.

Key details

  • The performance rights were issued under an employee incentive scheme. Not all performance rights of that type have been converted.
  • Key management personnel member Mr Justin Cahill converted 300,000 of the performance rights.
  • The new shares will rank equally in all respects with existing ordinary shares from their issue date.
  • After quotation, Starpharma will have 482,911,053 quoted ordinary fully paid shares and 33,721,157 unquoted performance rights. These figures are automatically generated and may not reflect current issued capital if other forms are still being processed by ASX.

What’s still pending

  • The new shares are intended to be, but are not yet, quoted on ASX.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/starpharma-application-for-quotation-of-securities-spl-1

Announcement Summary

Entity name

STARPHARMA HOLDINGS LIMITED

Announcement Type

New announcement

Date of this announcement

Friday October 30, 2026

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

ASX +security

code

Security description

Number of +securities to

be quoted Issue date

SPL

ORDINARY FULLY PAID

3,171,938 23/10/2026

Total number of +securities to be quoted

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

  1. Name of entity

    STARPHARMA HOLDINGS LIMITED

    We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

  2. Registered number type

    ABN

    Registration number

    20078532180

  3. ASX issuer code

    SPL

  4. The announcement is

    New announcement

  5. Date of this announcement

30/10/2026

Part 2 - Type of Issue

  1. The +securities to be quoted are:

    +Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

  2. The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class FROM (Existing Class)

ASX +security code and description

SPLAK : PERFORMANCE RIGHT

TO (Existing Class)

ASX +security code and description

SPL : ORDINARY FULLY PAID

Please state the number of options that were exercised or other

+convertible securities that were converted

3,171,938

The first date the options were exercised or other +convertible securities were converted

23/10/2026

The last date the options were exercised or other +convertible securities were converted

23/10/2026

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

An issue of new +securities

The underlying +securities being received by the holder are:

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

Yes

Provide details of the KMP or +associates who are exercising options or converting convertible securities

Number of options being exercised or other +convertible securities

Name of KMP Name of registered holder

being converted

Mr Justin Cahill

Mr Justin Cahill

300,000

Issue date

23/10/2026

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued

+securities in that class?

Yes

Issue details

Number of +securities to be quoted

3,171,938

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

Securities being issued are on conversion of vested employee performance rights to ordinary shares at no cost.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the

+securities to be quoted

0.000000

Any other information the entity wishes to provide about the +securities to be quoted

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

  1. Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the

    +securities subject of this application)

    ASX +security code and description

    Total number of

    +securities on issue

    SPL : ORDINARY FULLY PAID 482,911,053

  2. Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description

Total number of

+securities on issue

SPLAK : PERFORMANCE RIGHT 33,721,157

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

All Starpharma news releases